Summary

The global Nicotinamide Supplement market is projected to grow from US$ 286 million in 2025 to US$ 437 million by 2032, at a CAGR of 6.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
In 2025, global Nicotinamide Supplement production reached approximately 6,800 tons, with an average global market price of around USD 42 per kg.
The gross profit margin of major companies in the industry is between 30%–45%.
In 2025, the global production capacity of Nicotinamide Supplement was approximately 9,000 tons.
Nicotinamide Supplement is a nutritional supplement formulated with nicotinamide, a water-soluble form of vitamin B3. Nicotinamide is involved in energy metabolism and serves as a precursor for nicotinamide adenine dinucleotide and related coenzymes that support numerous cellular processes. Supplement products are available in tablets, capsules, powders, liquids, and other dosage forms, with formulations varying in nicotinamide concentration and additional ingredients. The product is primarily used for dietary vitamin B3 supplementation and nutritional support. It is distinct from prescription medicines and from cosmetic products containing nicotinamide as a topical active ingredient. Product quality is mainly evaluated through ingredient purity, dosage accuracy, stability, and formulation consistency.
The upstream industry supplies pharmaceutical or food-grade nicotinamide, excipients, binders, fillers, coatings, flavoring agents, capsules, and packaging materials. The midstream industry performs formulation development, weighing, blending, granulation, tableting or encapsulation, filling, quality testing, and packaging to produce finished supplements. Products are differentiated by dosage form, nicotinamide concentration, serving size, formulation composition, and packaging format. Downstream products are distributed through pharmacies, health-food retailers, e-commerce channels, and nutrition-oriented consumer markets. Demand is supported by consumer interest in vitamin supplementation, preventive nutrition, and convenient daily dietary supplements.
From a downstream perspective, Pharmacy Retail accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Nicotinamide Supplement leading manufacturers (including NOW Foods, Life Extension, Thorne HealthTech, Pure Encapsulations, Source Naturals, Swanson Health Products, Solgar, Inc., Nature's Way, Nutricost, Jarrow Formulas, etc.), dominate supply; the top five capture approximately % of global revenue, with NOW Foods leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Nicotinamide Supplement market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
NOW Foods
Life Extension
Thorne HealthTech
Pure Encapsulations
Source Naturals
Swanson Health Products
Solgar, Inc.
Nature's Way
Nutricost
Jarrow Formulas
Doctor's Best
Douglas Laboratories
ProThera Inc.
By-Health Co., Ltd.
Xiamen Kingdomway Group Company
Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd.
Tasly Holding Group
Renhe Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical Co., Ltd.
Segment by Type
Chewable Tablets
Effervescent Tablets
Oral Granules
Segment by Formulation Composition
Pure Nicotinamide Supplements
Nicotinamide-Vitamin Complexes
Nicotinamide-Mineral Complexes
Segment by Nicotinamide Dose
Low-Dose Products（≤50 mg/serving）
Medium-Dose Products（>50–250 mg/serving）
High-Dose Products（>250 mg/serving）
Segment by Application
Pharmacy Retail
Health Food Retail
Online Supplement Retail
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Nicotinamide Supplement study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Nicotinamide Supplement: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nicotinamide Supplement Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Chewable Tablets
1.2.3 Effervescent Tablets
1.2.4 Oral Granules
1.3 Market Segmentation by Formulation Composition
1.3.1 Global Nicotinamide Supplement Market Size by Formulation Composition, 2021 vs 2025 vs 2032
1.3.2 Pure Nicotinamide Supplements
1.3.3 Nicotinamide-Vitamin Complexes
1.3.4 Nicotinamide-Mineral Complexes
1.4 Market Segmentation by Nicotinamide Dose
1.4.1 Global Nicotinamide Supplement Market Size by Nicotinamide Dose, 2021 vs 2025 vs 2032
1.4.2 Low-Dose Products（≤50 mg/serving）
1.4.3 Medium-Dose Products（>50–250 mg/serving）
1.4.4 High-Dose Products（>250 mg/serving）
1.5 Market Segmentation by Application
1.5.1 Global Nicotinamide Supplement Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Pharmacy Retail
1.5.3 Health Food Retail
1.5.4 Online Supplement Retail
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Nicotinamide Supplement Revenue Estimates and Forecasts (2021-2032)
2.2 Global Nicotinamide Supplement Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Nicotinamide Supplement Sales Estimates and Forecasts (2021-2032)
2.4 Global Nicotinamide Supplement Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Nicotinamide Supplement Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Nicotinamide Supplement Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Chewable Tablets: Market Share by Key Manufacturers
3.5.2 Effervescent Tablets: Market Share by Key Manufacturers
3.5.3 Oral Granules: Market Share by Key Manufacturers
3.6 Global Nicotinamide Supplement Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Nicotinamide Supplement Sales Performance by Type
4.1.1 Global Nicotinamide Supplement Sales Volume by Type (2021-2032)
4.1.2 Global Nicotinamide Supplement Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Nicotinamide Supplement Sales Performance by Formulation Composition
4.2.1 Global Nicotinamide Supplement Sales Volume by Formulation Composition (2021-2032)
4.2.2 Global Nicotinamide Supplement Revenue by Formulation Composition (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Formulation Composition (2021-2032)
4.3 Global Nicotinamide Supplement Sales Performance by Nicotinamide Dose
4.3.1 Global Nicotinamide Supplement Sales Volume by Nicotinamide Dose (2021-2032)
4.3.2 Global Nicotinamide Supplement Revenue by Nicotinamide Dose (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Nicotinamide Dose (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Nicotinamide Supplement Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Nicotinamide Supplement Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Nicotinamide Supplement Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Nicotinamide Supplement Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Nicotinamide Supplement Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Nicotinamide Supplement Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Nicotinamide Supplement Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Nicotinamide Supplement Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Nicotinamide Supplement Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Nicotinamide Supplement Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Nicotinamide Supplement Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Nicotinamide Supplement Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 NOW Foods
11.1.1 NOW Foods Corporation Information
11.1.2 NOW Foods Business Overview
11.1.3 NOW Foods Nicotinamide Supplement Product Models, Descriptions and Specifications
11.1.4 NOW Foods Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 NOW Foods Nicotinamide Supplement Sales by Product in 2025
11.1.6 NOW Foods Nicotinamide Supplement Sales by Application in 2025
11.1.7 NOW Foods Nicotinamide Supplement Sales by Geographic Area in 2025
11.1.8 NOW Foods Nicotinamide Supplement SWOT Analysis
11.1.9 NOW Foods Recent Developments
11.2 Life Extension
11.2.1 Life Extension Corporation Information
11.2.2 Life Extension Business Overview
11.2.3 Life Extension Nicotinamide Supplement Product Models, Descriptions and Specifications
11.2.4 Life Extension Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Life Extension Nicotinamide Supplement Sales by Product in 2025
11.2.6 Life Extension Nicotinamide Supplement Sales by Application in 2025
11.2.7 Life Extension Nicotinamide Supplement Sales by Geographic Area in 2025
11.2.8 Life Extension Nicotinamide Supplement SWOT Analysis
11.2.9 Life Extension Recent Developments
11.3 Thorne HealthTech
11.3.1 Thorne HealthTech Corporation Information
11.3.2 Thorne HealthTech Business Overview
11.3.3 Thorne HealthTech Nicotinamide Supplement Product Models, Descriptions and Specifications
11.3.4 Thorne HealthTech Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Thorne HealthTech Nicotinamide Supplement Sales by Product in 2025
11.3.6 Thorne HealthTech Nicotinamide Supplement Sales by Application in 2025
11.3.7 Thorne HealthTech Nicotinamide Supplement Sales by Geographic Area in 2025
11.3.8 Thorne HealthTech Nicotinamide Supplement SWOT Analysis
11.3.9 Thorne HealthTech Recent Developments
11.4 Pure Encapsulations
11.4.1 Pure Encapsulations Corporation Information
11.4.2 Pure Encapsulations Business Overview
11.4.3 Pure Encapsulations Nicotinamide Supplement Product Models, Descriptions and Specifications
11.4.4 Pure Encapsulations Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Pure Encapsulations Nicotinamide Supplement Sales by Product in 2025
11.4.6 Pure Encapsulations Nicotinamide Supplement Sales by Application in 2025
11.4.7 Pure Encapsulations Nicotinamide Supplement Sales by Geographic Area in 2025
11.4.8 Pure Encapsulations Nicotinamide Supplement SWOT Analysis
11.4.9 Pure Encapsulations Recent Developments
11.5 Source Naturals
11.5.1 Source Naturals Corporation Information
11.5.2 Source Naturals Business Overview
11.5.3 Source Naturals Nicotinamide Supplement Product Models, Descriptions and Specifications
11.5.4 Source Naturals Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Source Naturals Nicotinamide Supplement Sales by Product in 2025
11.5.6 Source Naturals Nicotinamide Supplement Sales by Application in 2025
11.5.7 Source Naturals Nicotinamide Supplement Sales by Geographic Area in 2025
11.5.8 Source Naturals Nicotinamide Supplement SWOT Analysis
11.5.9 Source Naturals Recent Developments
11.6 Swanson Health Products
11.6.1 Swanson Health Products Corporation Information
11.6.2 Swanson Health Products Business Overview
11.6.3 Swanson Health Products Nicotinamide Supplement Product Models, Descriptions and Specifications
11.6.4 Swanson Health Products Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Swanson Health Products Recent Developments
11.7 Solgar, Inc.
11.7.1 Solgar, Inc. Corporation Information
11.7.2 Solgar, Inc. Business Overview
11.7.3 Solgar, Inc. Nicotinamide Supplement Product Models, Descriptions and Specifications
11.7.4 Solgar, Inc. Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Solgar, Inc. Recent Developments
11.8 Nature's Way
11.8.1 Nature's Way Corporation Information
11.8.2 Nature's Way Business Overview
11.8.3 Nature's Way Nicotinamide Supplement Product Models, Descriptions and Specifications
11.8.4 Nature's Way Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Nature's Way Recent Developments
11.9 Nutricost
11.9.1 Nutricost Corporation Information
11.9.2 Nutricost Business Overview
11.9.3 Nutricost Nicotinamide Supplement Product Models, Descriptions and Specifications
11.9.4 Nutricost Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Nutricost Recent Developments
11.10 Jarrow Formulas
11.10.1 Jarrow Formulas Corporation Information
11.10.2 Jarrow Formulas Business Overview
11.10.3 Jarrow Formulas Nicotinamide Supplement Product Models, Descriptions and Specifications
11.10.4 Jarrow Formulas Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Jarrow Formulas Recent Developments
11.11 Doctor's Best
11.11.1 Doctor's Best Corporation Information
11.11.2 Doctor's Best Business Overview
11.11.3 Doctor's Best Nicotinamide Supplement Product Models, Descriptions and Specifications
11.11.4 Doctor's Best Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Doctor's Best Recent Developments
11.12 Douglas Laboratories
11.12.1 Douglas Laboratories Corporation Information
11.12.2 Douglas Laboratories Business Overview
11.12.3 Douglas Laboratories Nicotinamide Supplement Product Models, Descriptions and Specifications
11.12.4 Douglas Laboratories Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Douglas Laboratories Recent Developments
11.13 ProThera Inc.
11.13.1 ProThera Inc. Corporation Information
11.13.2 ProThera Inc. Business Overview
11.13.3 ProThera Inc. Nicotinamide Supplement Product Models, Descriptions and Specifications
11.13.4 ProThera Inc. Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 ProThera Inc. Recent Developments
11.14 By-Health Co., Ltd.
11.14.1 By-Health Co., Ltd. Corporation Information
11.14.2 By-Health Co., Ltd. Business Overview
11.14.3 By-Health Co., Ltd. Nicotinamide Supplement Product Models, Descriptions and Specifications
11.14.4 By-Health Co., Ltd. Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 By-Health Co., Ltd. Recent Developments
11.15 Xiamen Kingdomway Group Company
11.15.1 Xiamen Kingdomway Group Company Corporation Information
11.15.2 Xiamen Kingdomway Group Company Business Overview
11.15.3 Xiamen Kingdomway Group Company Nicotinamide Supplement Product Models, Descriptions and Specifications
11.15.4 Xiamen Kingdomway Group Company Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Xiamen Kingdomway Group Company Recent Developments
11.16 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd.
11.16.1 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Corporation Information
11.16.2 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Business Overview
11.16.3 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Nicotinamide Supplement Product Models, Descriptions and Specifications
11.16.4 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Recent Developments
11.17 Tasly Holding Group
11.17.1 Tasly Holding Group Corporation Information
11.17.2 Tasly Holding Group Business Overview
11.17.3 Tasly Holding Group Nicotinamide Supplement Product Models, Descriptions and Specifications
11.17.4 Tasly Holding Group Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Tasly Holding Group Recent Developments
11.18 Renhe Pharmaceutical Group
11.18.1 Renhe Pharmaceutical Group Corporation Information
11.18.2 Renhe Pharmaceutical Group Business Overview
11.18.3 Renhe Pharmaceutical Group Nicotinamide Supplement Product Models, Descriptions and Specifications
11.18.4 Renhe Pharmaceutical Group Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Renhe Pharmaceutical Group Recent Developments
11.19 Guangzhou Kanghe Pharmaceutical Co., Ltd.
11.19.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Corporation Information
11.19.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
11.19.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Nicotinamide Supplement Product Models, Descriptions and Specifications
11.19.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Nicotinamide Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Nicotinamide Supplement Industry Chain
12.2 Nicotinamide Supplement Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Nicotinamide Supplement Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Nicotinamide Supplement Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Nicotinamide Supplement Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Nicotinamide Supplement Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Nicotinamide Supplement Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Nicotinamide Supplement Market Size Growth Rate by Formulation Composition, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Nicotinamide Supplement Market Size Growth Rate by Nicotinamide Dose, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Nicotinamide Supplement Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Nicotinamide Supplement Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Nicotinamide Supplement Revenue by Region (US$ Million), 2021-2026
Table 7. Global Nicotinamide Supplement Revenue by Region (US$ Million), 2027-2032
Table 8. Global Nicotinamide Supplement Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 9. Global Nicotinamide Supplement Sales by Region (Tons), 2021-2026
Table 10. Global Nicotinamide Supplement Sales by Region (Tons), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Nicotinamide Supplement Sales by Manufacturers (Tons), 2021-2026
Table 13. Global Nicotinamide Supplement Sales Share by Manufacturers (2021-2026)
Table 14. Global Nicotinamide Supplement Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Nicotinamide Supplement Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Nicotinamide Supplement Revenue, 2025
Table 18. Global Nicotinamide Supplement Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Nicotinamide Supplement Average Selling Price (ASP) by Manufacturers (US$/Ton), 2021-2026
Table 20. Key Manufacturers Nicotinamide Supplement Manufacturing Base and Headquarters
Table 21. Global Nicotinamide Supplement Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Nicotinamide Supplement Sales Volume by Type (Tons), 2021-2026
Table 25. Global Nicotinamide Supplement Sales Volume by Type (Tons), 2027-2032
Table 26. Global Nicotinamide Supplement Revenue by Type (US$ Million), 2021-2026
Table 27. Global Nicotinamide Supplement Revenue by Type (US$ Million), 2027-2032
Table 28. Global Nicotinamide Supplement Sales Volume by Formulation Composition (Tons), 2021-2026
Table 29. Global Nicotinamide Supplement Sales Volume by Formulation Composition (Tons), 2027-2032
Table 30. Global Nicotinamide Supplement Revenue by Formulation Composition (US$ Million), 2021-2026
Table 31. Global Nicotinamide Supplement Revenue by Formulation Composition (US$ Million), 2027-2032
Table 32. Global Nicotinamide Supplement Sales Volume by Nicotinamide Dose (Tons), 2021-2026
Table 33. Global Nicotinamide Supplement Sales Volume by Nicotinamide Dose (Tons), 2027-2032
Table 34. Global Nicotinamide Supplement Revenue by Nicotinamide Dose (US$ Million), 2021-2026
Table 35. Global Nicotinamide Supplement Revenue by Nicotinamide Dose (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Nicotinamide Supplement Sales by Application (Tons), 2021-2026
Table 38. Global Nicotinamide Supplement Sales by Application (Tons), 2027-2032
Table 39. Nicotinamide Supplement High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Nicotinamide Supplement Revenue by Application (US$ Million), 2021-2026
Table 41. Global Nicotinamide Supplement Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Nicotinamide Supplement Growth Accelerators and Market Barriers
Table 45. North America Nicotinamide Supplement Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Nicotinamide Supplement Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Nicotinamide Supplement Growth Accelerators and Market Barriers
Table 48. Europe Nicotinamide Supplement Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Nicotinamide Supplement Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Nicotinamide Supplement Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Nicotinamide Supplement Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Nicotinamide Supplement Growth Accelerators and Market Barriers
Table 53. Southeast Asia Nicotinamide Supplement Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Nicotinamide Supplement Investment Opportunities and Key Challenges
Table 55. Central and South America Nicotinamide Supplement Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Nicotinamide Supplement Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Nicotinamide Supplement Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. NOW Foods Corporation Information
Table 59. NOW Foods Description and Major Businesses
Table 60. NOW Foods Product Models, Descriptions and Specifications
Table 61. NOW Foods Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 62. NOW Foods Sales Value Proportion by Product in 2025
Table 63. NOW Foods Sales Value Proportion by Application in 2025
Table 64. NOW Foods Sales Value Proportion by Geographic Area in 2025
Table 65. NOW Foods Nicotinamide Supplement SWOT Analysis
Table 66. NOW Foods Recent Developments
Table 67. Life Extension Corporation Information
Table 68. Life Extension Description and Major Businesses
Table 69. Life Extension Product Models, Descriptions and Specifications
Table 70. Life Extension Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 71. Life Extension Sales Value Proportion by Product in 2025
Table 72. Life Extension Sales Value Proportion by Application in 2025
Table 73. Life Extension Sales Value Proportion by Geographic Area in 2025
Table 74. Life Extension Nicotinamide Supplement SWOT Analysis
Table 75. Life Extension Recent Developments
Table 76. Thorne HealthTech Corporation Information
Table 77. Thorne HealthTech Description and Major Businesses
Table 78. Thorne HealthTech Product Models, Descriptions and Specifications
Table 79. Thorne HealthTech Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. Thorne HealthTech Sales Value Proportion by Product in 2025
Table 81. Thorne HealthTech Sales Value Proportion by Application in 2025
Table 82. Thorne HealthTech Sales Value Proportion by Geographic Area in 2025
Table 83. Thorne HealthTech Nicotinamide Supplement SWOT Analysis
Table 84. Thorne HealthTech Recent Developments
Table 85. Pure Encapsulations Corporation Information
Table 86. Pure Encapsulations Description and Major Businesses
Table 87. Pure Encapsulations Product Models, Descriptions and Specifications
Table 88. Pure Encapsulations Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 89. Pure Encapsulations Sales Value Proportion by Product in 2025
Table 90. Pure Encapsulations Sales Value Proportion by Application in 2025
Table 91. Pure Encapsulations Sales Value Proportion by Geographic Area in 2025
Table 92. Pure Encapsulations Nicotinamide Supplement SWOT Analysis
Table 93. Pure Encapsulations Recent Developments
Table 94. Source Naturals Corporation Information
Table 95. Source Naturals Description and Major Businesses
Table 96. Source Naturals Product Models, Descriptions and Specifications
Table 97. Source Naturals Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 98. Source Naturals Sales Value Proportion by Product in 2025
Table 99. Source Naturals Sales Value Proportion by Application in 2025
Table 100. Source Naturals Sales Value Proportion by Geographic Area in 2025
Table 101. Source Naturals Nicotinamide Supplement SWOT Analysis
Table 102. Source Naturals Recent Developments
Table 103. Swanson Health Products Corporation Information
Table 104. Swanson Health Products Description and Major Businesses
Table 105. Swanson Health Products Product Models, Descriptions and Specifications
Table 106. Swanson Health Products Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 107. Swanson Health Products Recent Developments
Table 108. Solgar, Inc. Corporation Information
Table 109. Solgar, Inc. Description and Major Businesses
Table 110. Solgar, Inc. Product Models, Descriptions and Specifications
Table 111. Solgar, Inc. Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 112. Solgar, Inc. Recent Developments
Table 113. Nature's Way Corporation Information
Table 114. Nature's Way Description and Major Businesses
Table 115. Nature's Way Product Models, Descriptions and Specifications
Table 116. Nature's Way Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 117. Nature's Way Recent Developments
Table 118. Nutricost Corporation Information
Table 119. Nutricost Description and Major Businesses
Table 120. Nutricost Product Models, Descriptions and Specifications
Table 121. Nutricost Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 122. Nutricost Recent Developments
Table 123. Jarrow Formulas Corporation Information
Table 124. Jarrow Formulas Description and Major Businesses
Table 125. Jarrow Formulas Product Models, Descriptions and Specifications
Table 126. Jarrow Formulas Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 127. Jarrow Formulas Recent Developments
Table 128. Doctor's Best Corporation Information
Table 129. Doctor's Best Description and Major Businesses
Table 130. Doctor's Best Product Models, Descriptions and Specifications
Table 131. Doctor's Best Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 132. Doctor's Best Recent Developments
Table 133. Douglas Laboratories Corporation Information
Table 134. Douglas Laboratories Description and Major Businesses
Table 135. Douglas Laboratories Product Models, Descriptions and Specifications
Table 136. Douglas Laboratories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 137. Douglas Laboratories Recent Developments
Table 138. ProThera Inc. Corporation Information
Table 139. ProThera Inc. Description and Major Businesses
Table 140. ProThera Inc. Product Models, Descriptions and Specifications
Table 141. ProThera Inc. Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 142. ProThera Inc. Recent Developments
Table 143. By-Health Co., Ltd. Corporation Information
Table 144. By-Health Co., Ltd. Description and Major Businesses
Table 145. By-Health Co., Ltd. Product Models, Descriptions and Specifications
Table 146. By-Health Co., Ltd. Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 147. By-Health Co., Ltd. Recent Developments
Table 148. Xiamen Kingdomway Group Company Corporation Information
Table 149. Xiamen Kingdomway Group Company Description and Major Businesses
Table 150. Xiamen Kingdomway Group Company Product Models, Descriptions and Specifications
Table 151. Xiamen Kingdomway Group Company Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 152. Xiamen Kingdomway Group Company Recent Developments
Table 153. Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Corporation Information
Table 154. Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Description and Major Businesses
Table 155. Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 156. Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 157. Beijing Tong Ren Tang Xing'an Health Technology Co., Ltd. Recent Developments
Table 158. Tasly Holding Group Corporation Information
Table 159. Tasly Holding Group Description and Major Businesses
Table 160. Tasly Holding Group Product Models, Descriptions and Specifications
Table 161. Tasly Holding Group Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 162. Tasly Holding Group Recent Developments
Table 163. Renhe Pharmaceutical Group Corporation Information
Table 164. Renhe Pharmaceutical Group Description and Major Businesses
Table 165. Renhe Pharmaceutical Group Product Models, Descriptions and Specifications
Table 166. Renhe Pharmaceutical Group Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 167. Renhe Pharmaceutical Group Recent Developments
Table 168. Guangzhou Kanghe Pharmaceutical Co., Ltd. Corporation Information
Table 169. Guangzhou Kanghe Pharmaceutical Co., Ltd. Description and Major Businesses
Table 170. Guangzhou Kanghe Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 171. Guangzhou Kanghe Pharmaceutical Co., Ltd. Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 172. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
Table 173. Key Raw Materials Distribution
Table 174. Raw Materials Key Suppliers
Table 175. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 176. Milestones in Production Technology Evolution
Table 177. Distributors List
Table 178. Market Trends and Market Evolution
Table 179. Market Drivers and Opportunities
Table 180. Market Challenges, Risks, and Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources

List of Figures
Figure 1. Nicotinamide Supplement Product Picture
Figure 2. Global Nicotinamide Supplement Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Chewable Tablets Product Picture
Figure 4. Effervescent Tablets Product Picture
Figure 5. Oral Granules Product Picture
Figure 6. Global Nicotinamide Supplement Market Size Growth Rate by Formulation Composition, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Pure Nicotinamide Supplements Product Picture
Figure 8. Nicotinamide-Vitamin Complexes Product Picture
Figure 9. Nicotinamide-Mineral Complexes Product Picture
Figure 10. Global Nicotinamide Supplement Market Size Growth Rate by Nicotinamide Dose, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Low-Dose Products（≤50 mg/serving） Product Picture
Figure 12. Medium-Dose Products（>50–250 mg/serving） Product Picture
Figure 13. High-Dose Products（>250 mg/serving） Product Picture
Figure 14. Global Nicotinamide Supplement Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Pharmacy Retail
Figure 16. Health Food Retail
Figure 17. Online Supplement Retail
Figure 18. Other
Figure 19. Nicotinamide Supplement Report Years Considered
Figure 20. Global Nicotinamide Supplement Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 22. Global Nicotinamide Supplement Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Nicotinamide Supplement Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Nicotinamide Supplement Sales (Tons), 2021-2032
Figure 25. Global Nicotinamide Supplement Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 26. Global Nicotinamide Supplement Sales Market Share by Region (2021-2032)
Figure 27. Top 5 and Top 10 Manufacturers Nicotinamide Supplement Sales Volume Market Share in 2025
Figure 28. Global Nicotinamide Supplement Revenue-Based Market Share Ranking (2025)
Figure 29. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 30. Chewable Tablets Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Effervescent Tablets Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Oral Granules Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Global Nicotinamide Supplement Sales Volume-Based Market Share by Type (2021-2032)
Figure 34. Global Nicotinamide Supplement Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global Nicotinamide Supplement ASP by Type (US$/Ton), 2021-2032
Figure 36. Global Nicotinamide Supplement Sales Volume-Based Market Share by Formulation Composition (2021-2032)
Figure 37. Global Nicotinamide Supplement Revenue-Based Market Share by Formulation Composition (2021-2032)
Figure 38. Global Nicotinamide Supplement ASP by Formulation Composition (US$/Ton), 2021-2032
Figure 39. Global Nicotinamide Supplement Sales Volume-Based Market Share by Nicotinamide Dose (2021-2032)
Figure 40. Global Nicotinamide Supplement Revenue-Based Market Share by Nicotinamide Dose (2021-2032)
Figure 41. Global Nicotinamide Supplement ASP by Nicotinamide Dose (US$/Ton), 2021-2032
Figure 42. Global Nicotinamide Supplement Sales Market Share by Application (2021-2032)
Figure 43. Global Nicotinamide Supplement Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Nicotinamide Supplement ASP by Application (US$/Ton), 2021-2032
Figure 45. North America Nicotinamide Supplement Sales YoY (Tons), 2021-2032
Figure 46. North America Nicotinamide Supplement Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Nicotinamide Supplement Sales Revenue (US$ Million) in 2025
Figure 48. North America Nicotinamide Supplement Sales Volume (Tons) by Application (2021-2032)
Figure 49. North America Nicotinamide Supplement Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 51. Canada Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 52. Mexico Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 53. Europe Nicotinamide Supplement Sales YoY (Tons), 2021-2032
Figure 54. Europe Nicotinamide Supplement Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Nicotinamide Supplement Sales Revenue (US$ Million) in 2025
Figure 56. Europe Nicotinamide Supplement Sales Volume (Tons) by Application (2021-2032)
Figure 57. Europe Nicotinamide Supplement Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 59. France Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 60. U.K. Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 61. Italy Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 62. Russia Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Nicotinamide Supplement Sales YoY (Tons), 2021-2032
Figure 64. Asia-Pacific Nicotinamide Supplement Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Nicotinamide Supplement Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Nicotinamide Supplement Sales Volume (Tons) by Application (2021-2032)
Figure 67. Asia-Pacific Nicotinamide Supplement Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 69. Japan Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 70. South Korea Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 72. India Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Nicotinamide Supplement Sales YoY (Tons), 2021-2032
Figure 74. Central and South America Nicotinamide Supplement Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Nicotinamide Supplement Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Nicotinamide Supplement Sales Volume (Tons) by Application (2021-2032)
Figure 77. Central and South America Nicotinamide Supplement Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 79. Argentina Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Nicotinamide Supplement Sales YoY (Tons), 2021-2032
Figure 81. Middle East and Africa Nicotinamide Supplement Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Nicotinamide Supplement Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Nicotinamide Supplement Sales Volume (Tons) by Application (2021-2032)
Figure 84. Middle East and Africa Nicotinamide Supplement Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 86. Turkey Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 87. Egypt Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 88. South Africa Nicotinamide Supplement Revenue (US$ Million), 2021-2032
Figure 89. Nicotinamide Supplement Industry Chain Mapping
Figure 90. Regional Nicotinamide Supplement Manufacturing Base Distribution (%)
Figure 91. Global Nicotinamide Supplement Production Market Share by Region (2021-2032)
Figure 92. Nicotinamide Supplement Production Process
Figure 93. Regional Nicotinamide Supplement Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed